Health Condition 1: null- Chronic Cholestasis Liver Disease
Conditions
Interventions
Intervention1: Udiliv: Route - Oral. Dosage - As per
investigator discretion.Observation period of the study will be 8 weeks while the patient is on Udiliv treatment as permitted according by local la
Sponsors
Abbott India Limited
Eligibility
Inclusion criteria
Inclusion criteria: A patient can be included in the study if he/she meets all of the following inclusion criteria: 1. Adult male or non-pregnant female patient aged 18 to 65 years. 2. Presence of chronic CLD as diagnosed by the physician. 3. A patient in whom the decision to prescribe Udiliv (according to the local label) has been taken by the treating physician during the normal course of therapy. 4. Patient who has given written authorization to provide data for the study.
Exclusion criteria
Exclusion criteria: Patients presenting with any of the following criteria will not be eligible for the study: 1. Contraindications to Udiliv treatment (including hypersensitivity) according to the local label. 2. Hepatocellular or metastatic liver carcinoma. 3. Severe liver disease including but not limited to ascites, hepatic encephalopathy, hypoalbuminemia, coagulopathy. 4. Child Pugh C Classification as diagnosed by the physician 5. Pregnancy or lactation. 6. Concomitant use of hepatotoxic drugs 7. Previous enrollment in the present study. 8. Other conditions that make the patientâ??s participation impossible (by investigator judgment).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) To determine the profile of chronic CLD patients treated with Udiliv in the routine clinical care setting. (2) To gain insight into the decision making process of physicians prescribing Udiliv.Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To better understand the effectiveness, tolerability, and compliance of Udiliv therapy in the patient population with chronic CLD.Timepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactVishal Vaidya
Jehangir Hospital
Outcome results
None listed